Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Contact form








 


Note! If you want an answer on a question you must specify your email address




Magnus Gisslen

Professor/ chief physician

Magnus Gisslen
Professor/ chief physician
magnus.gisslen@infect.gu.se

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Östra sjukhuset , Göteborg


Department of Infectious Diseases at Institute of Biomedicine (More Information)
Box 480
405 30 Göteborg
0313421000
Visiting Address: Guldhedsgatan 10 A-B , 413 46 Göteborg

Latest publications

Antiretroviral treatment for HIV infection: Swedish recommendations 2019
J. Eriksen, C. Carlander, J. Albert, L. Flamholc, Magnus Gisslén et al.
Infectious Diseases, Journal article 2020
Journal article

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.
Claire Bridel, Wessel N van Wieringen, Henrik Zetterberg, Betty M Tijms, Charlotte E Teunissen et al.
JAMA neurology, Journal article 2019
Journal article

Potential for early antiretroviral therapy to reduce central nervous system HIV-1 persistence.
Serena Spudich, Julia Peterson, Dietmar Fuchs, Richard W Price, Magnus Gisslén
AIDS (London, England), Journal article 2019
Journal article

Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS.
Alan Winston, Andrea Antinori, Paola Cinque, Howard S Fox, Magnus Gisslén et al.
AIDS (London, England), Editorial letter 2019
Editorial letter

HIV-1 RNA Detected in the CNS after Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
Sarah B Joseph, Laura P Kincer, Natalie M Bowman, Chris Evans, Michael J Vinikoor et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Journal article 2019
Journal article

Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals.
Thomas A Premeaux, Michelle L D'Antoni, Mohamed Abdel-Mohsen, Satish K Pillai, Kalpana J Kallianpur et al.
Journal of neurovirology, Journal article 2019
Journal article

Showing 31 - 40 of 173

2017

Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
A. Haggblom, M. Santacatterina, U. Neogi, Magnus Gisslén, B. Hejdeman et al.
Plos One, Journal article 2017
Journal article

Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden
U. Neogi, A. B. Siddik, P. Kalaghatgi, Magnus Gisslén, G. Bratt et al.
Scientific Reports, Journal article 2017
Journal article

Antiretroviral treatment for HIV infection: Swedish recommendations 2016.
Jaran Eriksen, Jan Albert, Anders Blaxhult, Christina Carlander, Leo Flamholc et al.
Infectious diseases (London, England), Journal article 2017
Journal article

HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014
A. Haggblom, S. Lindback, Magnus Gisslén, L. Flamholc, B. Hejdeman et al.
Plos One, Journal article 2017
Journal article

2016

Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy
Hans Gaines, Jan Albert, Maria Axelsson, Torsten Berglund, Magnus Gisslén et al.
Infectious diseases (London, England), Journal article 2016
Journal article

Showing 31 - 40 of 173

Page Manager: Evelyn Vilkman|Last update: 8/28/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?